Normal view MARC view ISBD view

A five-year strategic financial plan for Sun Pharmaceutical Philippines, Inc / Barba, Joana Rose D., Barlaan Kaye Marie T., Borromeo, Beatriz C., Fulgar, Kyla Nicole S., Reyes, Cyrine Joy F., Rodriguez, Nicole, Ventenilla, Chrish Andrea H. 6

By: Barba, Joana Rose D., Barlaan Kaye Marie T., Borromeo, Beatriz C., Fulgar, Kyla Nicole S., Reyes, Cyrine Joy F., Rodriguez, Nicole, Ventenilla, Chrish Andrea H. 4 0 16, [, ] | [, ] |

Contributor(s): 5 6 [] |

Language: Unknown language code Summary language: Unknown language code Original language: Unknown language code Series: ; December 2023.46Edition: Description: 28 cm. 205 pagesContent type: text Media type: unmediated Carrier type: volumeISBN: ISSN: 2Other title: 6 []Uniform titles: | | Related works: 1 40 6 []Subject(s): -- 2 -- 0 -- -- | -- 2 -- 0 -- 6 -- | 2 0 -- | -- -- 20 -- | | -- -- -- -- 20 -- | -- -- -- 20 -- --Genre/Form: -- 2 -- Additional physical formats: DDC classification: | LOC classification: | | 2Other classification:

Contents:

Action note: In: Summary: Executive Summary Sun Pharmaceutical Industries, Ltd., India's largest pharmaceutical company and the world's fourth-largest generic pharmaceutical company, is a leading global provider of high-quality products. Established in 2011, Sun Pharma Philippines, Inc. is part of the emerging Asia branches of Sun Pharmaceutical Industries, Ltd. and focuses on distributing finished goods from its manufacturing facilities in Malaysia, Thailand, and India. The company uses an inside marketing strategy, targeting doctors for product promotion and employing wholesalers for distribution. Sun Pharma specializes in therapeutic categories like mental health, oncology, ophthalmology, dermatology, and gastroenterology, with a longer shelf life compared to competitors. The company is also committed to social responsibility, participating in donation drives for key healthcare institutions. The company's financial statements from 2019 to 2023 reveal inconsistent net profit despite consistent revenue growth. This highlights a persistent imbalance between expenses and revenue, where expenses consistently outpace income, negatively impacting the company's ability to meet its liabilities and maintain financial stability. This situation demands immediate attention and the implementation of strategic financial measures to address these ongoing challenges for the company. The proponents aim to improve Sun Pharma Philippines, Inc.'s inconsistent net profit despite consistent revenue growth by implementing a strategic financial plan. The plan analyzes the company's financial situation, identifying areas for improvement and suggesting alternative actions to minimize profitability challenges. This strategy approach intends to ensure financially stable and efficient operational future endeavors for Sun Pharma Philippines, Inc. Other editions:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings ( 1 )
Title notes
Comments ( 0 )

Item type	Current location	Home library	Collection	Call number	Status	Date due	Barcode	Item holds
Book	PLM	PLM Filipiniana Section	Filipiniana-Thesis	HG4001 B37 2023 (Browse shelf)	Available		FT8067

Total holds: 0

Browsing PLM Shelves , Shelving location: Filipiniana Section , Collection code: Filipiniana-Thesis Close shelf browser

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	HG4001 A68 2024 A Five-Year strategic financial plan for Panasonic	HG4001 B35 2023 Managing the risk towards sustainability of start up business by entrepreneurship students in Pamantasan ng Lungsod ng Maynila /	HG4001 B35 2024 A Six-Year strategic financial plan for Lorenzo Shipping Corporation	HG4001 B37 2023 A five-year strategic financial plan for Sun Pharmaceutical Philippines, Inc /	HG4001 B37 2024 A Five-Year Strategic Financial Plan for PXP Energy Corporation /	HG4001 B38 2022 A five-year strategic financial plan for Sorsogon II Electric Cooperative (SORECO II)	HG4001 B47 2024 The level of financial literacy and its influence on the current financial well-being of millennials in Manila City /	Next

Financial Plan: (BSBA major in Financial Management) - Pamantasan ng Lungsod ng Maynila, 2023. 56

Executive Summary Sun Pharmaceutical Industries, Ltd., India's largest pharmaceutical company and the world's fourth-largest generic pharmaceutical company, is a leading global provider of high-quality products. Established in 2011, Sun Pharma Philippines, Inc. is part of the emerging Asia branches of Sun Pharmaceutical Industries, Ltd. and focuses on distributing finished goods from its manufacturing facilities in Malaysia, Thailand, and India. The company uses an inside marketing strategy, targeting doctors for product promotion and employing wholesalers for distribution. Sun Pharma specializes in therapeutic categories like mental health, oncology, ophthalmology, dermatology, and gastroenterology, with a longer shelf life compared to competitors. The company is also committed to social responsibility, participating in donation drives for key healthcare institutions. The company's financial statements from 2019 to 2023 reveal inconsistent net profit despite consistent revenue growth. This highlights a persistent imbalance between expenses and revenue, where expenses consistently outpace income, negatively impacting the company's ability to meet its liabilities and maintain financial stability. This situation demands immediate attention and the implementation of strategic financial measures to address these ongoing challenges for the company. The proponents aim to improve Sun Pharma Philippines, Inc.'s inconsistent net profit despite consistent revenue growth by implementing a strategic financial plan. The plan analyzes the company's financial situation, identifying areas for improvement and suggesting alternative actions to minimize profitability challenges. This strategy approach intends to ensure financially stable and efficient operational future endeavors for Sun Pharma Philippines, Inc.

There are no comments for this item.

to post a comment.